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WILSON, M. C. AND C. R. SCHUSTER. Aminergic influences on intravenous cocaine self-administration by rhesus 
monkeys. PHARMAC. BIOCHEM. BEHAV. 2(5) 563-571, 1974. - Earlier observations have demonstrated that when 
allowed limited daily access to cocaine, monkeys self-administer approximately the same amount of cocaine dally. 
Treatment with neuroleptic agents increases the frequency of this behavior which could be interpreted as resulting from 
an antagonism of the reinforcing actions of cocaine. The present paper demonstrates that agents known to alter central 
aminergic systems affect cocaine self-administration. Acute treatment with pargyline (50 and 100 mg/kg) decreased the 
behavior; DL alpha-methylparatyrosine (50 mg/kg) increased the behavior. Treatment with the peripheral alpha 
adrenergic blocking agents phentolamine and phenoxybenzamine (0.5-8.0mg/kg) did not significantly alter the 
behavior. Chronic treatment (5-10days) with reserpine (0.1-1.0mg/kg) produced an initial increase in self- 
administration to which tolerance developed. Upon discontinuation of reserpine treatment, cocaine self-administration 
was decreased below baseline levels. Results tend to implicate either dopamine or norepinephrine as mediators of either 
cocaine-based reinforcement or of the other effects of cocaine which may regulate the frequency of its administration. 
Results were discussed in relation to those obtained from clinical studies in which drug effects on amphetamine-induced 
euphoria were ascertained. 
Cocaine self-administration Psychomotor stimulant Pargyline Phentolamine Drugs as reinforcers 
Phenoxybenzamine Alpha methylparatyrosine Reserpine Denervation supersensitivity 
THE intravenous self-administration of psychomotor stim- 
ulants by rhesus monkeys was originally demonstrated by 
Deneau etal. [3].  These investigators reported that the 
intravenous administration of cocaine and d-amphetamine 
initiated and maintained lever-pressing behavior. Several 
researchers [4, 9, 10, 12, 15, 17] have further demon- 
strated in both rats and rhesus monkeys that, when allowed 
da i ly  limited access to the drug, the amount self- 
administered per day was fairly constant within a subject. 
Total daily drug intake did not appreciably vary even 
though the dosage per injection or the size of a fixed ratio 
schedule of  reinforcement were altered over a wide range of 
values. The mechanisms underlying this behavioral stability 
have not been ascertained but it has been hypothesized that 
in addition to the positive reinforcing actions, that aversive 
or behavioral disrupting effects of these compounds limit or 
regulate the frequency of the behavior. 
S ince  animal self-administration experimentation is 
viewed by some as a model with which to study factors 
related to clinical drug abuse, it seemed reasonable to 
conduct studies to determine whether the reinforcing 
actions of psychomotor stimulants could be altered by 
treatment with other drugs. This method of  experimen- 
tation could be utilized to determine if specific agents 
could antagonize the reinforcing efficacy of  these com- 
pounds. Such agents might have clinical usefulness in the 
treatment of  stimulant drug dependence. 
Attempts to alter the stability of  intravenous psycho- 
motor  stimulant self-administration by the administration 
of other drugs as pretreatment medication prior to initia- 
ting a drug access period, have met with some success. 
Acute pretreatment with a-methylparatyrosine (AMPT) has 
been demonstrated to increase intravenous methamphet- 
amine self-administration in rats [ 1 1 ] while intraperitoneal 
methamphetamine pretreatment decreased the frequency of  
this behavior and pretreatment with 1-dopa had no signifi- 
cant effect. Data demonstrating the ability of AMPT to 
antagonize both the primary and secondary reinforcement 
associated with intravenous d-amphetamine self-administra- 
tion in rats have also been obtained [ 1,2]. 
Since many of the behavioral and physiological actions 
of the psychomotor stimulants have been attributed to 
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either an increase in adrenergic or dopaminergic activity, 
the following study was conducted in an attempt to provide 
additional data regarding the neurochemical basis of the 
reinforcement mechanisms associated with psychomotor 
stimulant self-administration. Furthermore, since previous 
data obtained in this laboratory indicated that pretreatment 
with CNS depressant drugs possessing neuroleptic activity 
facilitated this behavior, it appeared that aminergic mech- 
anisms could be involved in mediating the self-adminis- 
tration behavior. Therefore, the effects of administering 
agents,  known to centrally and/or peripherally alter 
aminergic activity, on cocaine self-administration behavior 
were ascertained. 
Phenoxybenzamine and phentolamine are alpha adrener- 
gic blocking agents and their ability to block peripheral 
alpha actions of norepinephrine and serotonin have been 
well documented [8].  However there is some question as to 
whether these agents block the effects of these substances 
in the central nervous system. Therefore, they are usually 
considered as being peripheral alpha adrenergic blocking 
agents. However depending on dosage and the route of 
administration sedation, hyperventilation, toss of time 
perception and convulsions have been reported in humans, 
These central effects could be direct in nature and unre- 
lated to any neurotransmitter blocking ability. 
Pargyline inhibits the enzyme monoamine oxidase which 
functions intraneuronally and extraneuronally in meta- 
bolizing norepinephrine, dopamine and serotonin; there- 
fore, the effects of drugs which are dependent on the 
amounts of these neurotransmitters may be enhanced by 
pargyline treatment. 
Alpha-methylparatyrosine (AMPT) inhibits the rate 
limiting step in the synethsis of dopamine and norepineph- 
rine without affecting serotonin synthesis. Therefore drug 
effects based on dopamine and norepinephrine may be 
reduced by prior treatment with AMPT [8].  
Reserpine following an initial release of norepinephrine, 
serotonin and dopamine causes a depletion of neuronal 
levels of these substances [8]. Therefore like AMPT, it 
should reduce drug effects due to the release of these 
substances. 
However, it must be recognized that not all of the 
effects of any drug capable of altering neurochemical trans- 
mission are necessarily attributable to this interaction with 
synaptic transmission. Their effects can also be direct in 
nature and furthermore effects which are thought to result 
from a direct action may later prove to have resulted from 
changes in monamine function or vice versa, 
METHOD 
Animals 
The animals for this study were adult, drug-naive male 
rhesus monkeys weighing 3 .8 -5 .6  kg. Each monkey was 
housed individually in an open-faced experimental cubicle 
con ta in ing  a response lever and stimulus light, and 
restrained by a stainless steel harness and arm assembly for 
the duration of the experiment [3].  The animals had free 
access to water and were fed at 8:00 a.m. and 4:00 p.m. 
After 7 days of adaptation to this environment, chronic 
indwelling jugular cannulae (i.d. = 0.81 mm, o.d. = 
1.62 ram) constructed of siliconized rubber were surgically 
implanted under pentobarbital anesthesia (30 mg/kg slowly 
administered intravenously). Following surgery, 600,000 
units of benzathine penicillin-G, mixed with 300,000 units 
of potassium penicitlin-G (All Purpose Bicillin Injection, 
Wyeth Laboratories) was administered intramuscularly as a 
prophylactic measure against infection resulting from the 
surgical procedure. 
General Procedure 
For 72 hr following surgery, each lever-press response 
exceeding 100 g of force and occurring during illumination 
of the stimulus light resulted in the intravenous administra- 
tion of 0.2 cc/kg of sterile physiological saline, During this 
period the stimulus light was constantly illuminated except 
during an injection cycle, A l l  lever-press responses were 
recorded on an Esterline Angus event recorder. Pro- 
grammed injections were administered every 4 hr in an 
effort to retard clot formation in the catheter. During this 
saline period, none of the animals emitted more than 
12 lever-press responses within any 24 hr segment. 
The saline solution was then replaced by a saline 
solution of cocaine hydrochloride which was prepared 
every 5 days. The stimulus light continued to be illumin- 
ated 24 hr a day for 5 days (except during an injection 
cycle). Each lever-press occurring while the fight was 
illuminated resulted in the administration of 0.2 mg/kg of 
cocaine hydrochloride. As previously, programmed injec- 
tions occurred every four hours. The duration of an 
injection cycle lasted from 3 5 - 5 0  sec depending on the 
animal's body weight. Each animal initiated self-adminis- 
tration behavior, well within this 5 day period. Drug access 
was then reduced to a daily (7 days a week) 4 hr session 
(10:00 a .m . -2 :00  p.m.). Drug availability was indicated by 
the illumination of the stimulus light. Lever-presses in the 
absence of the illuminated stimulus light were recorded but 
had no consequence. Within 2 weeks daily drug intake was 
stable (< 10% change in daily drug intake over 5 consecutive 
sessions) for each animal. Furthermore, stimulus control of 
each animal was well evidenced by the small number of 
responses (< 10) emitted by each animal during the 20 hr 
period separating successive sessions. Programmed injec- 
tions continued to be administered every 4 hr except during 
a daily session, If a catheter became inoperative during the 
course of the study, it was either replaced or a catheter 
implanted in the opposite internal jugular vein. If this 
occurred, a subsequent seven day reconditioning period was 
interposed to regain behavioral stability. 
Procedure Experiment  1 
This study utilized 8 animals divided into 2 groups of 4 
animals each. The effects of acute pretreatment with 
pargyline and phentolamine on stable cocaine self-adminis- 
tration behavior were ascertained in one group and the 
effect of acute pretreatment with phenoxybenzamine and 
a-methylparatyrosine determined in the other group. Five 
dosages  of phentolamine and of phenoxybenzamine 
(0 .5 -8 .0  mg/kg) were studied as were 5 dosages of par- 
gyline ( t . 0 - 1 0 0  mg/kg). All dosages were calculated on the 
basis  of  the  salt form. Four pretreatment dosages 
(1 .0 -50  mg/kg) of DL a-methylparatyrosine methyl ester 
(AMPT) (Regis Chemical Company, Chicago, Illinois) were 
investigated. All pretreatment solutions were prepared using 
a sterile physiological saline vehicle on the day on which 
they were administered. The solutions were refrigerated 
until 30 min prior to administration. Each animal in Group 1 
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was tested on one occasion with each dose of phentol- 
amine and pargyline; those in Group 2 were tested once 
with each dose of phenoxybenzamine and AMPT. Testing 
with all doses of the first drug was completed prior to 
initiating testing with the second drug. The sequence of 
dosage testing with each drug was randomized. The pre- 
treatment drug was administered intramuscularly 5 min 
prior to session onset. The pretreatment drug volume was 
kept constant at 0.5 cc with the concentration of the 
pretreatment solution being varied. Three sessions separated 
drug pretreatment sessions in which phentolamine or 
phenoxybenzamine were administered. Five days separated 
pargyline pretreatment sessions and 10 days separated 
AMPT pretreatment sessions. The various intervals were 
utilized in an attempt to insure no carry-over of drug 
effects from the previous pretreatment test session. Sessions 
in which 0.5 cc of sterile physiological saline were adminis- 
tered intramuscularly 5 min prior to session onset were 
interspersed between drug pretreatment sessions (after the 
frequency of self-administration behavior had returned to 
base-line value) to control for conditioning of the pretreat- 
ment procedure. The percentage change in cocaine self- 
administration seen in drug pretreatment sessions was 
compared to that which occurred in saline pretreatment 
sessions. 
Procedure Experiment 2 
Nine animals, randomly divided into 3 groups of 3 
animals each, were utilized in this particular study. Each 
group was chronically treated with either 0.1, 0.3 or 
1.0 mg/kg of reserpine. Treatment solutions were prepared 
daily using a vehicle of sterile physiological saline. Reser- 
pine was administered intramuscularly 30 min following the 
daily drug access period. The injection volume was held 
constant at 0.5 cc. This treatment procedure was followed 
for 10 consecutive sessions in the groups receiving the 0.1, 
and 0.3 mg/kg doses of reserpine. Reserpine, at a dosage of 
1.0 mg/kg, was administered for only 5 consecutive sessions 
because the dosage regimen was debilitating to the animals. 
The drug was administered post-session rather than pre- 
session in an attempt to produce the desired neurochemical 
effects without grossly altering animal behavior at the onset 
of and during the testing session. Prior to the onset of the 
reserpine treatment regimen, sterile physiological saline 
(0.5 cc) was administered in a similar manner for 5 consecu- 
tive sessions. The self-administration behavior emitted 
during this saline control period was compared to that 
which occurred during and for 3 sessions after the discon- 
t inuation of reserpine treatment. 
R E S U L T S  
Figure 1 illustrates that acute pretreatment with either 
of the alpha adrenergic blocking agents, phentolamine or 
phenoxybenzamine, in dosages of 0 .5 -8 .0  mg/kg did not 
significantly alter (p<0.05 via Student's T test) the fre- 
quency of cocaine self-administration behavior. The data 
shown in this figure represents the values for the total 
amount of cocaine administered during the daily session; 
however further analysis also indicated that the frequency 
of the behavior was also not altered in any particular hour 
of the session. There was gross evidence of the peripheral 
actions of the adrenergic blocking activity of these com- 
pounds. The amount of salivation exhibited by these 
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FIG. 1. Mean percentage change in cocaine self-administration as a 
function of the pretreatment dosage of phentolamine (o o) and 
phenoxybenzamine (u o). Each point represents the mean of 4 
animals and the vertical lines illustrate the range of change within 
these animals. The brackets at the left represent the range of change 
in cocaine self-administration which occurred following pretreat- 
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FIG. 2. Mean percentage change in cocaine self-administration as a 
function of the pretreatment dosage of pargyline (o o) and 
alpha methylparatyrosine, methylester (u u). Each point repre- 
sents the mean of 4 animals and the vertical lines illustrate the range 
of change within these animals. The brackets at the left represent 
the range of change in cocaine self-administration which occurred 
following pretreatment with saline. Five of these control sessions 
were conducted in each animal. An asterisk (*) denotes those points 
significantly different from saline (p<0.05). 
animals during saline pretreatment sessions as well as during 
non-pretreatment control sessions was much greater than in 
those sessions following pretreatment with either of these 
agents in dosages greater than 1.0 mg/kg. 
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FIG. 3. Alteration in hourly cocaine intake in 1 animal as a function of pretreatment dosage of pargyline. The height of the bars illustrate the 
amount of cocaine self-administered during that hour, following pretreatment with a given dosage of pargyline. The height of the vertical bars 
over the letter S represents mean cocaine intake in that period, following pretreatment with saline on 5 different occasions. The vertical lines 
represent the range of cocaine intake for these 5 control sessions. An asterisk (*) denotes those points significantly different from saline 
(p<0.05). 
The effects of  acute p re t rea tment  with the monamine  
oxidase (MAO) inhibi tor ,  pargyline, on cocaine-self- 
adminis t ra t ion  behavior  is i l lustrated in Fig. 2. Pre t rea tment  
with 1.0, 10 and 25 mg/kg of  pargyline did not  signifi- 
cantly alter the f requency  of  cocaine self-administrat ion 
behavior.  However ,  p re t rea tment  with 50 and 100 mg/kg  of  
pargyline decreased the f requency  of  this behavior  by an 
average of  15% and 25% respectively.  This effect  was 
evident  in 3 of  the 4 animals when treated with the 
50 mg/kg dose and in each of  the four  subjects fol lowing 
t r ea tment  with the 100 mg/kg  dose. During those sessions 
in which cocaine intake was depressed, the animals exhibi- 
ted peripheral  signs o f  sympathe t ic  act ivi ty  e.g., salivation 
and mydriasis;  of  a similar magni tude  as occurred in saline 
control  sessions during which more  cocaine was self- 
administered.  
Figure 3 il lustrates the t ime course of  the effects  of  
pargyline p re t rea tment  on cocaine self-administrat ion in a 
single animal.  This animal was typical  of  the group t reated 
with this substance. Al though pre t rea tment  with 1.0 mg/kg  
p r o d u c e d  no overall change in cocaine intake, self- 
adminis t ra t ion behavior  was slightly elevated in the third 
hour  of  the session. Drug intake during the o ther  3 hr  of  
the session was within the control  range obta ined f rom 
saline p re t rea tment  sessions. Al though  p re t rea tment  with 
10 mg/kg produced  no statistically significant change in 
cocaine self-administrat ion for the entire session, cocaine 
intake during the second and third hours of  the session 
were significantly reduced.  Pre t rea tment  with 25 mg/kg  
significantly decreased cocaine intake during the initial 3 hr 
of  the session but primari ly during the first hour.  However ,  
total  session drug intake across animals was not  signifi- 
cantly reduced by this dosage. Pre t rea tment  with 50 mg/kg  
decreased cocaine intake only during the initial hour  of  the 
session in this animal.  However,  in the o ther  3 animals 
intake was reduced in the first 3 hr of  the session. Pretreat- 
merit with 100 mg/kg  decreased cocaine self-administrat ion 
by at least 50% in the initial 2 hr of  the session in all 
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FIG. 4. Alteration in hourly cocaine intake in 1 animal as a function of the pretreatment dosage of alpha 
methylparatyrosine, methyl ester (AMFF). The height of the bars illustrates the amount of cocaine intake during that 
period, following pretreatment with a given dosage of AMPT. The height of the vertical bars over the letter S represents 
mean cocaine intake in that period, following pretreatment with saline on 5 different occasions. The vertical lines represent 
the range of cocaine intake for these 5 control sessions. An asterisk (*) denotes those points significantly different from 
saline (p<0.05). 
animals but intake had returned to control values by the 
fourth hour in all animals and by the third hour in 2 of the 
animals. 
The effects of acute pretreatment with the methyl ester 
of DL alpha methylparatyrosine (AMPT) on cocaine self- 
administration are illustrated in Fig. 2. Pretreatment with 
1.0 mg/kg did not produce any significant change in co- 
caine self-administration. Cocaine intake was increased by 
an average of 17% (range: +5% to +25%) following treat- 
ment with 10 mg/kg. Although this effect across animals 
was statistically insignificant, the increase seen in 3 of the 4 
animals was greater than that which occurred during any 
control session in those same animals. Likewise, pretreat- 
ment with 25 mg/kg did not produce any statistically 
significant change in the frequency of cocaine self-adminis- 
t r a t ion  across animals. However, cocaine intake was 
increased by an average of 19% (range: +3% to +37%) and 
the effect was greater than that seen during any control 
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FIG. 5. Mean percentage change in cocaine self-administration as a function of the dosage of reserpine treatment and as a 
function of the duration of reserpine treatment. Each point represents the mean of 3 animals and the vertical lines 
associated with each point indicate the range of percentage change within these animals. In those instances where no range 
is indicated the .point representing the mean covers the range. Open points represent sessions preceded by reserpine 
administration twenty hours previously. Closed points indicate no prior reserpine treatment. Those animals in which the 
0.1 and 0.3 mg/kg dosages were examined were treated with reserpine for 10 consecutive days; whereas, the group treated 
with 1.0 mg/kg of reserpine received this dosage for only 5 consecutive days (see text). The vertical lines at the left 
represent the range of percentage change in each group of 3 animals, for the 5 sessions preceeding the onset of reserpine 
treatment. During this period saline was administered in the same manner and pattern as the subsequent treatment with 
reserpine. An asterisk (*) denotes those points significantly different from saline within each group (p<0.05). 
session in 3 of  the 4 animals. A statist ically significant 
increase in mean cocaine self-administrat ion for the total  
session was produced  by p re t rea tment  wi th  50 mg/kg  of  
AMPT. This ef fec t  occurred in all animals and the average 
increase was 40% and the range of  the effect  was +23% to 
+47%. 
The t ime course of  the effect  of  AMPT on this behavior  
is i l lustrated in Fig. 4. The results represented in this illus- 
t ra t ion demons t r a t ed  those obta ined  f rom 1 animal which 
was fairly representat ive of  the o ther  3 animals. Pretreat-  
merit  with 1.0 mg/kg of  AMPT increased cocaine self- 
adminis t ra t ion  during the second hour  of  the session in this 
animal only. There was no o ther  effect  o f  this dosage of  
AMPT on hour ly  cocaine intake seen in this or  the o ther  3 
animals. Pre t rea tment  with 10 mg/kg  also p roduced  an 
increase in cocaine intake during the second hour  of  the 
session but hour ly  drug intake was within cont ro l  values 
during the o ther  hours o f  the session. A larger increase in 
self-administrat ion behavior  during the second and third 
hours of  the session was observed in the o ther  3 animals. 
Pre t rea tment  with 25 mg/kg  of  AMPT increased cocaine 
intake slightly during the first hour  of  the session in the 
animal whose data is i l lustrated. This effect  was absent  in 
the o ther  animals. This dose did significantly increase 
cocaine self-administrat ion in the remaining 3 hr of  the 
session in 3 of  the 4 animals. Pre t rea tment  with 50 mg/kg  
of  AMPT increased cocaine intake during the last 3 hr of  
the session in each animal and was the most  effect ive 
dosage tested. 
The effects  of  the chronic  adminis t ra t ion of  reserpine on 
cocaine self-administrat ion are i l lustrated in Fig. 5. Treat-  
ment  with a 0.1 mg/kg  of  reserpine 20 hr prior to the daily 
exper imenta l  session for 10 consecut ive sessions produced a 
statistically significant increase in cocaine intake in the 
third session fol lowing ini t iat ion of  reserpine t rea tment .  
The average increase in cocaine intake on this day was 22% 
(range: +18% to +26%). No significant change in drug 
intake occurred during the remaining 7 days of  t r ea tment  
with this dosage of  reserpine. However ,  on the day follow- 
ing the cessation of  reserpine t rea tment  (Day 11 ) i.e.,; 44 hr 
post-reserpine adminis t ra t ion,  mean cocaine intake was 
significantly decreased f rom initial saline cont ro l  values by 
9% (range: - 7 %  to - 1 0 % ) .  This effect  was absent on the 4 
succeeding cont ro l  days. 
T rea tmen t  with 0.3 mg/kg  of  reserpine increased mean 
cocaine intake by 25% (range: +10% to +42%) during the 
first session fol lowing ini t ia t ion o f  t rea tment .  Cocaine in- 
take was significantly increased in all 3 animals during this 
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session. Tolerance developed to this effect of reserpine. The 
rate at which this tolerance occurred varied greatly within 
the animal group which is indicated in Fig. 5 by the great 
variability in drug effect. Intake had returned to control  
values by the second session in 1 animal and by the third in 
another but not until the seventh session in the third 
animal. Furthermore,  in 2 of  the 3 animals drug intake was 
reduced below control values on Days 4, 5 and 6. The 
magnitude of this decrement ranged from 10% to 35% 
during this period. Cocaine self-administration returned to 
baseline values on Day 8 and remained there until  reserpine 
treatment was discontinued. No significant changes in 
cocaine self-administration occurred during the 5 days after 
cessation of t reatment  with this dosage of reserpine. 
Treatment with 1.0 mg/kg of  reserpine produced a 
significant increase in cocaine self-administration in the first 
3 sessions following treatment  initiation. The mean increase 
was greatest on the second day (x = 31%; range: 17% to 
48%). Drug intake returned to control  levels in 2 of the 3 
animals on Days 4 and 5 following the initiation of reser- 
pine treatment.  This dose of reserpine unlike the 0.1 and 
0.3 mg/kg dosages produced ptosis, diarrhea, and a neuro- 
lept ic  syndrome. Prior to session onset the animals 
exhibited ptosis and appeared lethargic and very sedated; 
however, at the onset of the stimulus associated with 
cocaine availability, i.e., stimulus light illumination, re- 
sponding began with little delay and priming injections 
were unnecessary. Treatment with this dosage of reserpine 
was limited to 5 days since gross evidence of debili tation 
was present and the animals food and water intake were 
greatly decreased. The ptosis, diarrhea, and the neuroleptic 
syndrome were absent by the second day following cessa- 
tion of reserpine treatment.  Mean cocaine intake was 
significantly reduced below control  levels on the first (32%) 
and second (19%) day following withdrawal of the reser- 
pine. This effect was seen in each of the 3 animals. Drug 
intake returned to control  values by the third day following 
discontinuation of reserpine treatment.  Both the initial 
increase in mean cocaine intake which occurred during the 
initial 3 days of reserpine treatment and the decrement in 
mean cocaine intake seen following the cessation of 
reserpine administration were dose dependent and greatest 
in magnitude with the 1.0 mg/kg dose. 
DISCUSSION 
The lack of effect of t reatment with either phentolamine 
or phenoxybenzamine on cocaine self-administration behav- 
ior apparently indicates that activation of peripheral alpha 
adrenergic receptors does not play any role in modulating 
behavior maintained by cocaine reinforcement. These 
agents have significant alpha adrenergic blocking action [8] 
and are clinically used for this effect. The lack of salivation, 
mydriasis and piloerection which normally accompanied 
the intake of cocaine was evidence that these agents in the 
dosages administered, were effective in blocking the periph- 
eral alpha adrenergic actions of systemically administered 
cocaine. Similar dosages of  phentolamine administered 
intramuscularly reduce the mean arterial blood pressure and 
increase heart rate in squirrel monkeys [7] .  Therefore, 
there is no question that the dosage of phentolamine 
exerted peripheral effects. However, whether sufficient 
central levels of this drug were achieved by this route of 
administration is uncertain. It has been demonstrated that 
treatment with phenoxybenzamine does not block but  
rather slightly enhances the subjective euphoric effects of 
amphetamine administered i.v. [5] .  This study used a single 
blind technique and involved 10 subjects with a prior 
history of  intravenous amphetamine use. A self-rating scale 
was utilized for registration of the subject 's  feeling of 
euphoria after amphetamine.  These authors hypothesized 
on the basis of the effect of this drug and others on 
amphetamine-based euphoria, that dopaminergic neurons 
were  involved  in mediating the subjective euphoric 
response. From the present data one can assume that 
perhaps central alpha-adrenergic systems either are not 
involved in mediating cocaine-based reinforcement or in 
mediating cocaine self-administration behavior or that 
sufficient quantities of phentolamine or phenoxybenzamine 
were not available to interact with these systems. 
The  decrement in cocaine self-administration seen 
following treatment with the monamine oxidase inhibitor 
pargyline may have occurred due to a potent iat ion of the 
effects of cocaine. Increases in the unit dosage of cocaine 
result in a decrease in the frequency of self-administration 
behavior [4, 12, 15, 17]. Pargyline increases the intra- 
neuronal levels of dopamine, serotonin and norepinephrine 
in dopaminergic, serotonerglc and adrenergic nerves respec- 
tively by virtue of inhibiting metabolism of these biogenic 
amines by MAO. Pargyline treatment conceivably could 
result in the availability of even more dopamine, serotonin 
or norepinephrine in the synaptic cleft region following 
activation of the appropriate neurons. This increase in 
aminergic activity may increase the efficacy and duration of 
action of each unit dose of cocaine which results in a 
decrease in the frequency of self-administration. Therefore, 
it is feasible to consider that the effeects of cocaine might 
also be enhanced by the concurrent administration of an 
MAO inhibitor. It has been hypothesized that behavioral 
disrupting and/or aversive effects of cocaine which could be 
mediated by dopaminergic, serotonergic or adrenergic 
systems may function in controlling or limiting cocaine 
self-administration [12,15].  The pargyline data would 
support this concept. Pargyline may potentiate  the rate- 
limiting effect and therefore reduce the frequency of 
cocaine self-administration behavior. Pargyline t reatment  
did potentiate the peripheral actions of the cocaine i.e., 
quantitatively similar autonomic effects were produced by 
a smaller dose of cocaine following pargyline treatment.  It 
was grossly evident that the decrement in cocaine self- 
administration behavior was not due to motor  incapaci- 
tat ion or sedation. 
The  increase  in cocaine self-administration which 
occurred following treatment with AMPT has also been 
observed in rats which self-administered methamphetamine 
intravenously [ 11 ]. The present increase in self-adminis- 
tration behavior may have resulted from an antagonism or 
partial extinction of the reinforcing property of cocaine. If 
one decreases the unit dosage of cocaine a similar increase 
in responding results [4, 12, 15, 17]. Further evidence to 
support  this hypothesis has been demonstrated in humans. 
Treatment with AMPT (0.5 and 1.5 g which would be 
approximately equivalent to 7 and 21 mg/kg respectively in 
a 70 kg person) significantly antagonized the subjective 
euphoric response to intravenously administered amphet-  
amine [5].  Tolerance developed to this amphetamine 
antagonism within 7 days of  treatment.  AMPT is an 
inhibitor of the enzyme tyrosine hydroxylase which is the 
enzyme which functions in the rate limiting step in the 
synthesis of dopamine and norepinephrine [14].  Whether 
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the effects seen in this research were due to a depletion of 
central norepinephrine or of dopamine is not known since 
it has not been determined which of these transmitters is 
involved in mediating cocaine-based reinforcement. 
However, another interpretation of the AMPT data 
would be that perhaps the decrease in dopaminergic or 
adrenergic activity may result in a decrease in those hypo- 
thetical actions of cocaine which may terminate its self- 
administration. However, in view of the clinical experience, 
the former hypothesis concerning the mechanism of 
AMPT's effect on this behavior appears to be the more 
tenable. Furthermore, other investigators have demon- 
strated the ability of AMPT to block both primary and 
conditioned reinforcement associated with intravenous 
d-amphetamine self-administration in rats [ 1,2]. 
The effects of chronic treatment with reserpine on 
cocaine self-administration are interesting. One could 
explain the initial rise in cocaine intake which was directly 
proportional to the dose of reserpine and whose latency 
was inversely proportional to the dose of reserpine, on the 
basis of this drug's abilit3 / to deplete monamines (sero- 
tonin, dopamine, norepinephrine). This effect would be 
similar to that of AMPT in that less dopamine and norepi- 
nephrine would be available for release from dopaminergic 
or adrenergic nerves. If those substances are involved either 
in mediating the reinforcing action of cocaine or in con- 
trolling cocaine self-administration then the initial increase 
in self-administration behavior is explainable. 
The ability of cocaine to antagonize many of the effects 
of reserpine was evident in those subjects receiving the 
1.0 mg/kg dose of reserpine. Ptosis, sedation, diarrhea in 
evidence at the onset of the session were rapidly antago- 
nized by the cocaine within thirty minutes. 
The decrease in self-administration behavior below 
control values which occurred when the reserpine was 
withdrawn is very difficult to interpret. If one assumes 
though that receptor sensitivity to these neurotransmitters 
has increased due to lack of these substances resulting from 
the effects of reserpine on amine metabolism, then upon 
removal of the reserpine the receptors may still be super- 
sensitive to these substances for several hours. If the 
reinforcing action of cocaine is mediated by these sub- 
stances then it would take less cocaine to produce the 
desired effect. Furthermore, if self-administration behavior 
is limited by actions of these same substances the behavior 
would be emitted at a reduced frequency even though less 
cocaine had been administered. 
Such a supersensitivity mechanism may also be responsi- 
ble for the development of tolerance to the initial increase 
in self-administration behavior, produced by reserpine. It 
has also been reported that tolerance develops to tile 
depression in locomotor activity produced by reserpine in 
rats during a ten day chronic treatment regimen. By the end 
of the treatment period, reserpine enhanced locomotor 
activity as compared to controls [ 13 ]. The initial effect was 
greatest during the third and fourth daily session. Tolerance 
has been demonstrated to develop within seven days to the 
ability of AMPT to antagonize the reinforcing effect of 
intravenous amphetamine in humans, perhaps via a similar 
mechanism [5]. 
Tolerance does not develop to the increase in intra- 
venous cocaine self-administration in monkeys produced by 
chlorpromazine during a 5 day treatment period [ 16]. One 
might  expect these agents i.e., reserpine and chlor- 
promazine, to similarly effect this behavior since both are 
considered as neuroleptic agents and since both can antago- 
nize many actions of psychomotor stimulants. They do 
differ in that whereas reserpine reduces levels of dopamine 
and norepinephrine, chlorpromazine supposedly blocks 
their receptors thereby not allowing the receptors to 
become supersensitive to the transmitter. Tolerance to the 
ability of the neuroleptics to block amphetamine-induced 
euphoria in humans has not been reported [ 5 ]. 
In general the data presented in this study tend to 
further implicate the central stores of dopamine and norepi- 
nephrine as functioning in mediating cocaine self-adminis- 
t r a t i o n  behavior. Although conceivably, serotonergic 
transmission may also influence this behavior and the 
effects of pargyline and reserpine pretreatment may be a 
reflection of this interaction. These two agents produce 
diametrically opposed changes in central serotonergic 
activity and produce opposite effects on the present behav- 
ior. Whether or not these biogenic amines mediate the 
reinforcing efficacy or mediate other effects of cocaine, 
which as well control the frequency of the behavior, re- 
mains to be ascertained. However, in view of tile high 
correlation between the results of this study and those 
obtained by Gunne et  aL (in humans) this study further 
signifies the acceptability of using the rhesus monkey as a 
model in which to investigate the reinforcing properties of 
the psychomotor stimulants. 
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